Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001069530-19-000057
Filing Date
2019-12-16
Accepted
2019-12-16 16:03:54
Documents
1
Period of Report
2019-12-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT certent-form4.html 4  
1 PRIMARY DOCUMENT certent-form4.xml 4 3899
  Complete submission text file 0001069530-19-000057.txt   5406
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XOMA, LTD. 2910 SEVENTH STREET BERKELEY CA 94710
Business Address
SCANNON PATRICK J MD PHD (Reporting) CIK: 0001222790 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29959 | Film No.: 191287082